Cepheid (CPHD +16%) jumps after reporting a solid Q2. Revenue easily topped estimates on strong...
Cepheid (CPHD +16%) jumps after reporting a solid Q2. Revenue easily topped estimates on strong growth in its clinical segment and international sales. Baird analyst Quintin Lai comments in a note the company's results "continue to impress."
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs